BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 5651948)

  • 1. [Character disorders and their treatment by pipamperone].
    Fouks ; Périvier ; Houssalt ; Gilbert ; Ferragu
    Ann Med Psychol (Paris); 1968 Feb; 1(2):255-8. PubMed ID: 5651948
    [No Abstract]   [Full Text] [Related]  

  • 2. Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study.
    Van Renynghe de Voxvrie G; De Bie M
    Acta Psychiatr Belg; 1976; 76(4):688-95. PubMed ID: 1020694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation.
    Deberdt R
    Acta Psychiatr Belg; 1976; 76(1):157-66. PubMed ID: 970185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution to the study of the effect of propericiazine on character and behavior disorders observed in children and adolescents].
    Duché DJ; Bourcier G
    Rev Neuropsychiatr Infant; 1969 Mar; 17(3):165-71. PubMed ID: 4389568
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of personality and behavior disorders in childhood epilepsy with Neuleptil].
    Nagayama T; Takeshita K; Kurakawa T
    No To Shinkei; 1967 Sep; 19(9):935-40. PubMed ID: 4866508
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the current possibilities of drug therapy of drug therapy of abnormalities of behavior of the character type in infants and children].
    Zucchi M
    Minerva Med; 1970 Oct; 61(82):4542-50. PubMed ID: 5474918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psychodynamic and sociodynamic changes produced by methylperidol].
    Leal R
    Actas Luso Esp Neurol Psiquiatr; 1969 Oct; 28(4):299-305. PubMed ID: 5394271
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of character disorders with a new butyrophenone: R. 3345 or pipamperone].
    Fouks ; Mathis ; Gilbert ; Ferragu ; Houssait ; Lerno
    Ann Med Psychol (Paris); 1966 Dec; 124(5):677-81. PubMed ID: 5973302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating severe maladjustment with pipamperone (Dipiperon).
    Noordhuizen GJ
    Acta Psychiatr Belg; 1977; 77(6):754-60. PubMed ID: 610354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neulactil (pericyazine) in the behaviour disturbances of institutionalized mental defectives.
    Daneel AB
    S Afr Med J; 1967 Oct; 41(39):995-8. PubMed ID: 6081157
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disorders of character in the evolutive age. (Review and personal considerations)].
    Mastrangelo G
    Osp Psichiatr; 1967; 35(2):365-84. PubMed ID: 4882317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Psychological approach to psychopharmacologic experimentation. Polycentric controlled study on the action of a new therapeutic agent in adolescents affected with character and personality disturbances].
    Galli PF; Alberti G; Bencini Bariatti MA; Cozzarini M; Micali C
    Clin Ter; 1969 Apr; 49(2):147-65. PubMed ID: 4947949
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution to the treatment of character and behavior disorders by propericiazine as compared with earlier treatments].
    Filipe-Lourenço A; Lécuyer R; Koupernik C
    Rev Neuropsychiatr Infant; 1966; 14(7):617-24. PubMed ID: 4382962
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bad character and Neuleptil. Apropos of a Belgian and Luxembourgian clinical experiment (1963-1964)].
    Bobon J; Gernay JM; Collard J; Goffioul F; Breulet M
    Acta Neurol Psychiatr Belg; 1968 Feb; 68(2):154-62. PubMed ID: 4387055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some results of the use of propericiazine (RP 8909) in the treatment of disorders of conduct and character in children and adolescents].
    Litinschi G; Fehervary E; Ciumăgeanu D
    Neurol Psihiatr Neurochir; 1970; 15(6):493-504. PubMed ID: 4396039
    [No Abstract]   [Full Text] [Related]  

  • 17. [Utilization of propericiazine in treatment of character disorders in mentally retarded children and adolescents].
    Vaneck L
    Rev Neuropsychiatr Infant; 1969 Aug; 17(8):557-61. PubMed ID: 4391428
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sedalium in psychiatry within its tranquilizing and neuroleptic boundaries].
    Volmat R; Beaudouin JL; Allers G; Vittouris N; Dufay F; Bizouard P
    Encephale; 1972; 61(2):163-82. PubMed ID: 4634905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of oligophrenic children and adolescents with propericiazine].
    Dostál T
    Act Nerv Super (Praha); 1968 Oct; 10(3):319. PubMed ID: 4387432
    [No Abstract]   [Full Text] [Related]  

  • 20. [Iatrogenic errors in treatment with tranquilizing agents].
    Krynski S
    Pediatr Prat; 1965; 36(5):154-9. PubMed ID: 5845509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.